https://www.pharmaceutical-technology.com/data-insights/nkx-019-nkarta-waldenstrom-macroglobulinemia-lymphoplasmacytic-lymphoma-likelihood-of-approval/
NKX-019 is under clinical development by Nkarta and currently in Phase I for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma).
waldenstrom macroglobulinemialymphoplasmacytic lymphomankxlikelihood
https://www.pharmaceutical-technology.com/data-insights/nkx-019-nkarta-lupus-nephritis-likelihood-of-approval/
NKX-019 is under clinical development by Nkarta and currently in Phase I for Lupus Nephritis.
lupus nephritisnkxlikelihoodapproval
https://www.nasdaq.com/market-activity/stocks/nkx/sec-filings
Find the latest SEC Filings data for Nuveen California AMT-Free Quality Municipal Income Fund (NKX) including 10-K and 10-Q forms at Nasdaq.com.
income fundnuveencaliforniaamtfree